|
Volumn 48, Issue 6, 1998, Pages 651-657
|
Pharmacological and pharmacokinetic studies of the newly synthesized thiazolidinedione derivative 5-(4-(1-phenyl-1- cyclopropanecarbonylamino)benzyl)thiazolidine-2,4-dione
a a a a a a a a |
Author keywords
5 (4 (1 Phenyl 1 cyclopropanecarbonylamino)benzyl)thiazolidine 2,4 dione; Antidiabetic agents; CAS 195604 21 8; CAS 97322 87 7; DN 108, pharmacokinetics, pharmacology; Thiazolidinedione derivatives; Troglitazone
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 (4 (1 PHENYL 1 CYCLOPROPANECARBONYLAMINO)BENZYL)THIAZOLIDINE 2,4 DIONE;
DEOXYGLUCOSE;
DN 108;
EPALRESTAT;
TROGLITAZONE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG ACTIVITY;
DRUG INDICATION;
DRUG SCREENING;
HYPERGLYCEMIA;
HYPERINSULINEMIA;
HYPERTRIGLYCERIDEMIA;
MALE;
MOUSE;
MUSCLE CELL;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RAT;
ALDEHYDE REDUCTASE;
ANIMALS;
BLOOD GLUCOSE;
CHROMANS;
DEOXYGLUCOSE;
ENZYME INHIBITORS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MALE;
MICE;
MICE, INBRED STRAINS;
MICROTUBULES;
RATS;
RATS, SPRAGUE-DAWLEY;
THIAZOLES;
THIAZOLIDINEDIONES;
TRIGLYCERIDES;
|
EID: 0031752289
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (31)
|